LCNB Corp’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $330K | Sell |
11,747
-25
| -0.2% | -$666 | 0.11% | 145 |
|
|
2025
Q4 | $293K | Buy |
11,772
+25
| +0.2% | +$630 | 0.1% | 156 |
|
|
2025
Q3 | $299K | Sell |
11,747
-1,291
| -10% | -$31.9K | 0.1% | 149 |
|
|
2025
Q2 | $316K | Sell |
13,038
-305
| -2% | -$7.11K | 0.11% | 153 |
|
|
2025
Q1 | $338K | Sell |
13,343
-26,557
| -67% | -$695K | 0.12% | 143 |
|
|
2024
Q4 | $1.06M | Buy |
39,900
+250
| +0.6% | +$6.78K | 0.39% | 65 |
|
|
2024
Q3 | $1.15M | Buy |
39,650
+252
| +0.6% | +$7.35K | 0.41% | 58 |
|
|
2024
Q2 | $1.1M | Buy |
39,398
+2,758
| +8% | +$75.9K | 0.41% | 54 |
|
|
2024
Q1 | $1.02M | Buy |
36,640
+860
| +2% | +$23.9K | 0.37% | 68 |
|
|
2023
Q4 | $1.03M | Buy |
35,780
+957
| +3% | +$28.9K | 0.41% | 62 |
|
|
2023
Q3 | $1.16M | Sell |
34,823
-3
| -0% | -$106 | 0.51% | 47 |
|
|
2023
Q2 | $1.28M | Sell |
34,826
-1,418
| -4% | -$55.2K | 0.54% | 46 |
|
|
2023
Q1 | $1.48M | Buy |
36,244
+785
| +2% | +$33.9K | 0.67% | 36 |
|
|
2022
Q4 | $1.82M | Buy |
35,459
+890
| +3% | +$42.7K | 0.84% | 27 |
|
|
2022
Q3 | $1.51M | Sell |
34,569
-1,040
| -3% | -$50.5K | 0.82% | 28 |
|
|
2022
Q2 | $1.87M | Buy |
35,609
+400
| +1% | +$20.4K | 0.97% | 24 |
|
|
2022
Q1 | $1.82M | Sell |
35,209
-547
| -2% | -$28.4K | 0.86% | 31 |
|
|
2021
Q4 | $2.11M | Buy |
35,756
+1,280
| +4% | +$63.4K | 0.96% | 26 |
|
|
2021
Q3 | $1.48M | Buy |
34,476
+1,830
| +6% | +$81.1K | 0.75% | 31 |
|
|
2021
Q2 | $1.28M | Buy |
32,646
+775
| +2% | +$30.1K | 0.64% | 38 |
|
|
2021
Q1 | $1.16M | Sell |
31,871
-1,681
| -5% | -$59.7K | 0.63% | 42 |
|
|
2020
Q4 | $1.24M | Sell |
33,552
-1,812
| -5% | -$66.5K | 0.7% | 37 |
|
|
2020
Q3 | $1.23M | Sell |
35,364
-706
| -2% | -$24.8K | 0.8% | 33 |
|
|
2020
Q2 | $1.12M | Buy |
36,070
+240
| +0.7% | +$8.15K | 0.76% | 32 |
|
|
2020
Q1 | $1.11M | Buy |
35,830
+2,120
| +6% | +$72.2K | 0.87% | 29 |
|
|
2019
Q4 | $1.25M | Buy |
33,710
+462
| +1% | +$16.5K | 0.76% | 34 |
|
|
2019
Q3 | $1.13M | Buy |
33,248
+2,463
| +8% | +$89.6K | 0.73% | 36 |
|
|
2019
Q2 | $1.26M | Buy |
30,785
+47
| +0.2% | +$1.87K | 0.89% | 28 |
|
|
2019
Q1 | $1.24M | Buy |
30,738
+732
| +2% | +$29.3K | 0.9% | 29 |
|
|
2018
Q4 | $1.24M | Sell |
30,006
-488
| -2% | -$20.3K | 1.03% | 28 |
|
|
2018
Q3 | $1.27M | Buy |
30,494
+824
| +3% | +$31.7K | 0.9% | 30 |
|
|
2018
Q2 | $1.02M | Buy |
29,670
+2,603
| +10% | +$89K | 0.92% | 29 |
|
|
2018
Q1 | $911K | Sell |
27,067
-1,349
| -5% | -$46.4K | 0.82% | 32 |
|
|
2017
Q4 | $977K | Sell |
28,416
-211
| -0.7% | -$7.2K | 0.86% | 30 |
|
|
2017
Q3 | $969K | Sell |
28,627
-356
| -1% | -$11.4K | 0.91% | 32 |
|
|
2017
Q2 | $924K | Sell |
28,983
-764
| -3% | -$24.1K | 0.9% | 32 |
|
|
2017
Q1 | $965K | Sell |
29,747
-699
| -2% | -$22K | 0.92% | 31 |
|
|
2016
Q4 | $938K | Buy |
+30,446
| New | +$929K | 0.93% | 29 |
|
Other funds holding PFE
VCM
VPM
LCNB Corp's PFE Position: Q1 2026 in Review
LCNB Corp reduced its Pfizer (PFE) stake by 0.21% in Q1 2026, selling an estimated $666 and leaving 11,747 shares worth $330K. The position accounts for 0.11% of the portfolio, ranked #145.
LCNB Corp first reported a position in PFE in Q4 2016 and has held it in 38 quarters since. The position peaked at $2.11M in Q4 2021. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- LCNB Corp held 11,747 shares of Pfizer worth $330K as of Q1 2026.
- LCNB Corp sold 25 Pfizer shares in Q1 2026, an estimated $666.
- Pfizer made up 0.11% of LCNB Corp's portfolio in Q1 2026, its #145 holding.
- LCNB Corp first reported a position in Pfizer in Q4 2016 and has held it in 38 quarters since.
- LCNB Corp's Pfizer position peaked at $2.11M in Q4 2021.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on LCNB Corp's 13F filing for Q1 2026, filed 11 May 2026.